Sensitive Detection of Rare Circulating Neuroblastoma Cells by the Reverse Transcriptase-Polymerase Chain Reaction

Cancer Research

Volumn 52, Issue 17, 1992, Pages 4701-4705

  Moss, Thomas J ^c,d   Emerson, Stephen G ^a,b  

^a Division of Hematology Oncology   (United States)

^b Internal Medicine ^*  (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

^d CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; RNA DIRECTED DNA POLYMERASE; TUMOR MARKER;

AGAR GEL ELECTROPHORESIS; ARTICLE; BONE MARROW DISEASE; CANCER DIAGNOSIS; CANCER RECURRENCE; DIAGNOSIS; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; MONONUCLEAR CELL; NEUROBLASTOMA CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SOUTHERN BLOTTING; STEM CELL; TUMOR CELL;

BASE SEQUENCE; GENE EXPRESSION; HUMAN; MOLECULAR SEQUENCE DATA; NEUROBLASTOMA; NEUROPEPTIDES; OLIGODEOXYRIBONUCLEOTIDES; POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, NEOPLASM; RNA-DIRECTED DNA POLYMERASE; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0026706299     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Crist, W. Mm and Kun, L. E. Common solid tumors of childhood. N. Engl. J. Med., 124: 461-471, 1991.
2. Silber, J. H., Evans, A. E., and Fridman, M. Models to predict outcome from childhood neuroblastoma: the role of serum ferritin and tumor histology. Cancer Res., 51: 1426-1433, 1991.
3. Brodeur, G. M., and Fong, C. Molecular biology and genetics of human neuroblastoma. Cancer Genet. Cytogenet., 41: 153-174, 1989.
4. Fong, C., Dracopoli, N. C., White, P. S., et al. Loss of heterozygosity for the short arm of chromosome 1 in human neuroblastomas: correlation with N-myc amplification. Proc. Natl. Acad. Sci. USA, 86: 3753-3757, 1989.
5. Taylor, S. R., Blatt, J., Costantino, J. P., et al. Flow cytometric DNA analysis of neuroblastoma and ganglioneuroma. Cancer (Phila.), 62: 749-754, 1988.
6. Moss, T. J., Reynolds, C. P., Sather, H. N., et al. Prognostic value of immu-nocytologic detection of bone marrow metastases in neuroblastoma. N. Engl. J. Med., 124: 219-226, 1991.
7. Moss, T. J., and Sanders, D. G. Detection of neuroblastoma cells in blood. J. Clin. Oncol., 8: 736-740, 1990.
8. Sambrook, J., Fritsch, E. F., and Maniatis, T. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 1989.
9. Lasky, L. C., Bostrom, B., Smith, J., et al. Clinical collection and use of peripheral blood stem cells in pediatric patients. Transplantation (Baltimore), 47:613, 1989.
10. Treleaven, J. G., Gibson, F. M., Ugelstad, J., et al. Removal of neuroblastoma cells from bone marrow with monoclonal antibodies conjugated to magnetic microspheres. Lancet, 1: 70-73, 1984.
11. Moss, T. J., Sanders, D. G., Lasky, L. C., et al. Contamination of peripheral blood stem cell harvests by circulating neuroblastoma cells. Blood, 76: 1879-1883, 1990.
12. Wilkinson, K. D., Lee, K., Deshpande, S., et al. The neuron-specific protein PGP 9.5 is a ubiquitin carboxyl-terminal hydrolase. Science (Washington DC), 246: 670-673, 1989.
13. Thompson, R. J., Doran, J. F., Jackson, P., et al. PGP 9.5-a new marker for vertebrate neurons and neuroendocrine cells. Brain Res., 278: 224-228, 1983.
14. Doran, J. F., Jackson, P., Kynoch, P. A. M., etal. Isolation of PGP 9.5, a new human neurone-specific protein detected by high resolution two-dimensional electrophoresis. J. Neurochem., 40: 1542-1547, 1983.
15. Day, I. N. M., and Thompson, R. J. Molecular cloning of cDNA coding for human PGP 9.5 protein. FEBS Utt., 210: 157-160, 1987.
16. Day, I. N. M., Hinks, L. J., and Thompson, R. J. The structure of the human gene encoding protein gene product 9.5 (PGP 9.5), a neuron-specific ubiquitin C-terminal hydrolase. Biochem. J., 268: 521-524, 1990.
17. Roth, M. S., Antin, J. H., Bingham, E. L., et al. Detection of Philadelphia chromosome-positive cells by the polymerase chain reaction following bone marrow transplant for chronic myelogenous leukemia. Blood, 74: 882-885, 1989.
18. Yokota, S., Hansen-Hagge, T. E., Ludwig, W. D., et al. Use of polymerase chain reactions to monitor minimal residual disease in acute lymphoblastic leukemia patients. Blood, 77: 331-339, 1991.
19. Schwab, M., Alitalo, K., Klempnauer, K. H., et al. Amplified DNA with limited homology to myc cellular oncogene is shared by human neuroblastoma cell lines and a neuroblastoma tumour. Nature (Lond.), 305:245-248, 1983.
20. Brodeur, G. M., Seeger, R. C., Schwab, M., et al. Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage. Science (Washington DC), 224: 1121-1124, 1984.
21. Seeger, R. C., Brodeur, G. M., Sather, H., et al. Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas. N. Engl. J. Med., 313: 1111-1116, 1985.
22. Schwab, M., Ellison, J., Busch, M., et al. Enhanced expression of the human gene v-myc consequent to amplification of DNA may contribute to malignant progression of neuroblastoma. Proc. Natl. Acad. Sci. USA, 81: 4940-4944, 1984.